End Gain-of-FUnction Research
By: Sam alexander
Dr. Francis Boyle is one of the world’s most consummate experts on biowarfare. He is the Illinois law professor who drafted the Biological Weapons Anti-Terrorism Act of 1989. In 2015, he stated that America was in violation of the 1972 Biological Weapons Convention; in 2020, he publicly advocated for a nationwide shutdown of all biosafety level 3 and 4 labs. His recommendations deserve attention.
The scientific research being conducted in these biosafety labs (BSL-3, BSL-4) is a dark world. A brief perusal of available information on this topic is enough to give you nightmares. Although the stockpiling of biological weapons supposedly ended decades ago, research that incorporates genetically modifying or engineering high-risk organisms still goes on today. In fact, a 2014 moratorium on gain-of-function research was halted in 2017. Gain-of-function research entails the practice of genetically engineering biological agents to deliberately enhance their harmful characteristics beyond the intensity of their natural predecessors. Some of the world’s most elite scientists, like Dr. Anthony Fauci, champion this research as necessary. It occurs under the justification of preempting a pandemic through the discovery of potential cures. However, it remains incontrovertible fact that someone cannot have a biological weapon without first having the prophylactic. This is a two-way street. Additionally, it necessitates the creation of problems we supposedly want to prevent.
SARS-Cov-2, a bat coronavirus said to be derived from a wet market in Wuhan, serves as a grave reminder that humanity must stop manipulating and tinkering with deadly pathogens. We must find a different way to prepare for biosecurity threats and advance the peaceful application of science. If a natural virus can do this much damage to planetary civilization, it seems clear that the accidental or intentional release of an augmented high-risk biological agent from a BSL-3 or BSL-4 lab would imply even more serious consequences. COVID-19 itself will also probably be subjected to these forms of enhancement inside these labs into more deadly forms. Is this not crazy?
The case fatality rates between COVID-19 and Ebola virus disease can be compared to illustrate the big picture. The case fatality rate describes the proportion of people who die from a disease, typically acute infectious disease, out of the total number who are diagnosed with it. According to official estimates, the case fatality ratio of COVID-19 in the United States is hovering at around 1.81%. This means 181 people die from COVID-19 out of 10,000 who are infected. By contrast, Ebola, on the Select Agents and Toxins List of the Federal Select Agent Program (run by the CDC and USDA), has an average case fatality ratio of 50%. This means, on average, 1 out of every 2 people infected with Ebola dies. If Ebola has been or ever could be engineered to enhance its transmission capabilities, many more millions of lives could be at risk. This is a science fiction dystopia waiting to happen.
Ebola’s natural form is dangerous enough. That is why it can only be studied within a BSL-4 laboratory. In fact, there are only 13 BSL-4 labs in America that are either already operational or under construction. In 2001, there were only 4. A number of other very dangerous pathogens are also only eligible for study in BSL-4 conditions. For imagery purposes, BSL-4 labs require technicians and researchers to utilize gloveboxes and don full astronaut-style suits before they enter spaces containing these pathogens in order to prevent exposure.
Despite safety precautions, leaks and accidents are all too common. The internet is littered with reports of biosafety labs in America and across the world being admonished, reprimanded, fined and even temporarily shut down for serious safety oversights. The CDC’s own labs have some of the worst safety records and are very secretive about accidents. On the other side of the world, Singapore, Taiwan and China have had their own problems. Between summer of 2003 and spring of 2004, each one of these countries had incidents with the SARS virus that resulted in the infection of at least one person. (These infections were also initially “traced to” animal reservoirs.) More recently, State Department cables warned about safety issues and management oversights at the Wuhan Institute of Virology (WIV) just within the past number of years. This institute is equipped with China’s first official BSL-4 laboratory. EcoHealth Alliance (an American NGO conducting research at the WIV) received millions of dollars in funding from the U.S. government to surveil, collect, and at least test the pathogenesis of certain bat coronavirus samples at that lab. Dr. Andrew Huff, a former employee at EcoHealth Alliance, has stated that gain-of-function research was being performed through this funding.
Professor Yoshihiro Kawaoka, from the University of Wisconsin-Madison, controversially engineered the H1N1 flu virus to escape neutralizing antibodies in a BSL-2 lab. UW-Madison was criticized by international media for allowing this research to happen in such a low-level lab. Professor Richard Ebright, a biologist at Rutgers, stated that “Kawaoka, single-handedly, has rendered useless the billions of dollars and millions of person-hours expended in mass vaccination against the 2009 pandemic influenza virus and, single-handedly, has placed millions of lives at risk…”. This professor’s team at Madison has also recreated a bird flu only 3% different from the 1918 Spanish flu. An escape could mean another pandemic.
In addition, even when our government and scientists have altruistic intentions and ideal precautions, we always risk a technology transfer scenario leveraged for geopolitical hegemony by hostile nation-states. Our education systems have already been heavily infiltrated—which is where this research primarily occurs. In fact, in January of 2020, two Chinese nationals and the Harvard Chemistry Department Chair were arrested by the FBI for stealing “biological research” (former) and aiding the Communist Chinese Party (former and latter). This research is too dangerous. Official taxpayer funding to the Wuhan Institute of Virology finally came to a complete standstill July of 2023; three and a half years after it became the center of controversy in the COVID-19 saga. But have no doubts this research still continues elsewhere. Write your federal representatives and tell them it’s time to stop funding death science.
SOURCES:
David Cyranoski, “Inside the Chinese Lab Poised to Study World’s Most Dangerous Pathogens.” Nature 542, (2017): 399-401.
Dennis Normile, “Mounting Lab Accidents Raise SARS Fears.” Science 304, no. 5671 (2004): 659-661.
Dr. Andrew Huff, The Truth About Wuhan (Skyhorse Publishing, 2022), 92.
Lisa Schnirring, “Feds Lift Gain-of-Function Research Pause, Offer Guidance.” University of Minnesota, CIDRAP. December 19, 2017. https://www.cidrap.umn.edu/dual-use-research/feds-lift-gain-function-research-pause-offer-guidance.
Mike Magnuson. “The 1918 Flu Killed 40 Million People. This Man Is Re-Creating the Virus.” Popular Mechanics. October 7, 2014, https://www.popularmechanics.com/science/health/a12897/the-man-who-could-destroy-the-world-breakthrough-awards-2014/.
Riley Griffin, “US Stops Funding for Chinese Lab at Center of Covid Controversy.” Bloomberg. July 18, 2023. https://www.bloomberg.com/news/articles/2023-07-18/us-suspends-wuhan-institute-funds-over-covid-stonewalling.
Sharon Lerner, Mara Hvistendahl and Maia Hibbett. “NIH Documents Provide New Evidence U.S. Funded Gain-Of-Function Research In Wuhan.” The Intercept. September 9, 2021. https://theintercept.com/2021/09/09/covid-origins-gain-of-function-research/.
Sherwood Ross. “U.S. Biowarfare Programs Have 13,000 Death Scientists Hard at Work.” LewRockwell.com. March 17, 2020. https://www.lewrockwell.com/2020/03/no_author/u-s-biowarfare-programs-have-13000-death-scientists-hard-at-work/.
Vineet D Menachery, Boyd L Yount Jr, Kari Debbink, Sudhakar Agnihothram, Lisa E Gralinski1, Jessica A Plante, Rachel L Graham et al., “A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.” Nature Medicine 21, no. 12 (2015): 1508-1513.